Month: March 2022

Rafael Holdings Reports Second Quarter Fiscal 2022 Financial Results

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

NEWARK, N.J., March 17, 2022 (GLOBE NEWSWIRE) — Rafael Holdings, Inc. (NYSE: RFL), an early-stage novel cancer and immune metabolism therapeutics company, today reported its financial results for the three and six months ended January 31, 2022. The end of our second fiscal quarter marks a beginning for the reorganized and focused Rafael Holdings with Bill Conkling assuming the responsibilities of Chief Executive Officer from Ameet Mallik as of February 1, 2022. The Company is focused on accelerating the development of our novel cancer and immune metabolism pipeline and exploring external opportunities to enhance the value of our company. “We are fortunate to have a core team of high caliber experienced senior pharmaceutical executives to lead R&D and the critical operational functions of the Company. We are enthusiastic about...

Usio Announces Record Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

Full Year Revenues up 92% as Fourth Quarter Revenues Rise 86% Fifth Consecutive Year of Record Revenue Strong Momentum Expected to Drive Continued Growth with 18-20% Increase in Revenue and Continued Positive Adjusted EBITDA Anticipated in Fiscal 2022 SAN ANTONIO, March 17, 2022 (GLOBE NEWSWIRE) — Usio, Inc: (Nasdaq:USIO), a leading, cloud-based, integrated FinTech electronic payment solutions provider, today announced financial results for the fourth quarter and year 2021, which ended December 31, 2021. Louis Hoch, President and Chief Executive Officer of Usio, said, “The fourth quarter was a strong finish to a year of record financial performance, with revenue for the year of $61.9 million, up 92% and positive adjusted EBITDA increasing by nearly $5 million compared to 2020. For the quarter, revenues were a record $17.4 million,...

Root, Inc. to Participate in the Jefferies Insurtech Conference

Written by Customer Service on March 17, 2022. Posted in Public Companies.

COLUMBUS, Ohio, March 17, 2022 (GLOBE NEWSWIRE) — Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance, today announced that Alex Timm, Co-Founder and CEO, will participate in a fireside chat at the Jefferies Insurtech Conference on Monday, March 21, 2022 at 4:20 p.m. ET. The fireside chat will be available live on the Jefferies website, and a replay of the webcast will be available for a limited time after the presentation concludes. About Root, Inc.  Root, Inc. is the parent company of Root Insurance Company. Root is revolutionizing insurance through data science and technology to provide consumers a personalized, easy, and fair experience. Media: press@joinroot.com Investor Relations: Christine Patrick VP, Investor Relations and Treasurer ir@joinroot.c...

CymaBay Announces Appointment of Éric Lefebvre, M.D. to Board of Directors

Written by Customer Service on March 17, 2022. Posted in Public Companies.

NEWARK, Calif., March 17, 2022 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced the appointment of Dr. Éric Lefebvre to its Board of Directors. “We are excited to be welcoming Éric to the Board. Éric’s extensive experience in the pharmaceutical industry as an executive focused on clinical development, medical affairs, business development and life-cycle strategy and more than 10 years of experience developing drugs in liver disease indications make him a perfect addition to our Board. We look forward to Éric helping guide us through our next phase of development and commercialization,” said Dr. Robert Wills, CymaBay’s Chairman of the Board. “We are incredibly fortunate...

SightGlass Vision Joint Venture Begins Operation

Written by Customer Service on March 17, 2022. Posted in Public Companies.

EssilorLuxottica and CooperCompanies initiative accelerates commercialization of innovative myopia management technologies CHARENTON-LE-PONT, France and SAN RAMON, Calif., March 17, 2022 (GLOBE NEWSWIRE) — EssilorLuxottica and CooperCompanies are pleased to announce the finalization of their joint venture agreement for SightGlass Vision. This collaboration of two global vision care leaders accelerates the commercialization of novel spectacle lens technologies to expand the myopia management category. SightGlass Vision’s Diffusion Optics Technology™ incorporates thousands of micro-dots into the lens that softly scatter light to reduce contrast on the retina, which is intended to reduce myopia progression in children.1 “As a global leader with a 30-year track record in myopia research, we have been developing the myopia management...

EssilorLuxottica: SightGlass Vision Joint Venture Begins Operation

Written by Customer Service on March 17, 2022. Posted in Mergers And Acquisitions.

SightGlass Vision Joint Venture Begins Operation EssilorLuxottica and CooperCompanies initiativeaccelerates commercialization of innovative myopia management technologies Charenton-le-Pont, France and San Ramon, California (March 17, 2022) – EssilorLuxottica and CooperCompanies are pleased to announce the finalization of their joint venture agreement for SightGlass Vision. This collaboration of two global vision care leaders accelerates the commercialization of novel spectacle lens technologies to expand the myopia management category. SightGlass Vision’s Diffusion Optics Technology™ incorporates thousands of micro-dots into the lens that softly scatter light to reduce contrast on the retina, which is intended to reduce myopia progression in children.1 “As a global leader with a 30-year track record in myopia research, we have been developing...

KULR Technology Group Inc. Reports Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

Fourth Quarter 2021 Revenue and Full-Year 2021 Revenue Up 267% and 287% Year-Over-Year Respectively SAN DIEGO, March 17, 2022 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leading developer of next-generation lithium-ion battery safety and thermal management technologies, today announced its financial results for the fourth quarter and full-year 2021. “This past calendar year was a pivotal period in our corporate history as we achieved numerous milestones across the business,” said KULR CEO Michael Mo. “With the goal to maintain our growth trajectory, the entire team is laser focused on executing against key objectives in 2022. More specifically, we will continue to focus on the core growth sectors: energy storage, e-mobility and safe transportation of...

IN8bio Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

All patients treated with INB-200, in clinical development for the treatment of glioblastoma multiforme (GBM), have shown a well-tolerated safety profile and longer than anticipated progression free survival (PFS) to date. All patients treated with INB-100, in clinical development for the treatment of leukemia undergoing hematopoietic stem cell transplantation (HSCT), have remained in remission, two for more than 1.5 years. Closed initial public offering raising gross proceeds of $40 million to advance genetically modified gamma-delta T cell therapeutic candidates into clinical development and to expand the pipeline.NEW YORK, March 17, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative gamma-delta T cell therapies utilizing...

JOANN Announces Fourth Quarter and Full Year Fiscal 2022 Results

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

Fiscal 2022 revenue of $2.4 billion, reflecting comparable sales growth of 8.3% compared to Fiscal 2020 Net income of $56.7 million, compared to $212.3 million in Fiscal 2021 and a loss of $(546.6) million in Fiscal 2020 Two-year growth rate of 10% for gross profit and 14% for adjusted gross profit compared to Fiscal 2020 Adjusted EBITDA of $242.5 million, reflecting a two-year growth rate of 58% compared to Fiscal 2020 New strategic partnerships and newly acquired customers provide strong foundation for continued growthHUDSON, Ohio, March 17, 2022 (GLOBE NEWSWIRE) — JOANN Inc. (NASDAQ: JOAN) (“JOANN”), the nation’s category leader in sewing and one of the fastest growing competitors in the arts and crafts category, today reported results for its fourth quarter and full year ended January 29, 2022. “We’ve now completed our...

Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2021

Written by Customer Service on March 17, 2022. Posted in Earnings Releases And Operating Results.

Summit Therapeutics perceives multiple opportunities to expand across the microbiome therapeutics field Cambridge, MA, March 17, 2022 (GLOBE NEWSWIRE) — Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today reports its financial results and provides an update on its operational progress for the fourth quarter and year ended December 31, 2021. Note: A glossary of terms is included at the end of this document to allow for the ease of understanding of terms or concepts used throughout this release. Operational & Corporate UpdatesSummit Therapeutics intends to implement a strategy that centers on microbiome-focused therapeutics. Modern medicine is pushing the boundaries of a new, increasingly patient friendly era: successfully treating disease while reducing associated...

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals